AmerisourceBergen Corporation today pronounced the culmination of its acquisition of the majority of Walgreens Boots’ Alliance Healthcare associations for $6.275 billion in cash, subject to a customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen normal stock.
“We are anxious to complete the acquisition and loosen up a warm welcome to the talented team at Alliance Healthcare,” said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen. “The acquisition of Alliance Healthcare expands our reach and solutions in drug distribution and adds to AmerisourceBergen’s breadth and significance of overall manufacturer services. With Alliance Healthcare, we will drive our ability to give inventive and overall clinical consideration solutions and further our inspiration of being participated in our responsibility to improve possibilities.”
“This trade gives phenomenal benefit to the two associations and is a canny development after the continued with accomplishment of our drawn out fundamental relationship,” said Ornella Barra, Chief Operating Officer, International, Walgreens Boots Alliance, Inc. “The Alliance Healthcare teams are joining an overall medication distribution pioneer and trusted partner in AmerisourceBergen, and we expect continuing to participate as fundamental partners.” AmerisourceBergen and Walgreens Boots Alliance will moreover execute on the expansion and extension of commercial agreements to drive progressive turn of events and synergies.
